Загрузка...
Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC
BACKGROUND: Renal cell carcinoma (RCC) is notorious for its resistance towards chemotherapy and radiation therapy in general. Combination therapy is often helpful in alleviating the resistance mechanisms by targeting multiple signaling pathways but is usually more toxic than monotherapy. Co-encapsul...
Сохранить в:
| Опубликовано в: : | Int J Nanomedicine |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6636461/ https://ncbi.nlm.nih.gov/pubmed/31371950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S204221 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|